Last €16.60 EUR
Change Today -0.094 / -0.56%
Volume 0.0
GM0N On Other Exchanges
Symbol
Exchange
New York
Frankfurt
As of 2:02 AM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

2560 General Armistead Avenue

Audubon, PA 19403

United States

Phone: 610-930-1800

Fax: 610-930-2042

Globus Medical, Inc., a medical device company, focuses on the design, development, and commercialization of products that promote healing in patients with spine disorders. Strategy The company’s business strategies include develop both Innovative Fusion products and Disruptive Technology products using product development engine; penetrate existing markets and to enter new markets by increasing the size and geographic scope of its U.S. sales force; expand into international markets; and pursue strategic acquisitions and alliances. Products The company offers approximately 110 Innovative Fusion and Disruptive Technology products. Innovative Fusion The company’s products address the entire spine with Innovative Fusion products for use in cervical, thoracolumbar, sacral, and interbody/corpectomy fusion procedures to treat degenerative, deformity, tumor, and trauma conditions. Its comprehensive REVERE pedicle screw and rod system incorporates a convenient non-threaded locking cap design that eases building of thoracolumbar fixation constructs to adapt to the patient’s anatomy and condition, for a range of clinical applications. Certain other of the company’s products, such as its XPAND and FORTIFY corpectomy devices that incorporate smooth expansion capability, has a range of size options for optimal fit, and are manufactured from radiolucent polyetheretherketone to allow for postoperative radiographic visualization. Certain of the company’s other products, such as its COALITION and INDEPENDENCE interbody fusion devices, simplify the surgical technique by reducing steps and hardware while providing confident stabilization. The company also builds on technologies to upgrade its offerings, including multiple cervical plating systems, both top-loading and posted screw systems, and a range of interbody implant and approach options. . Its Innovative Fusion products address a range of spinal fusion surgical procedures. Spinal fusion is a surgical procedure to correct problems with the individual vertebrae, the interlocking bones making up the spine, by preventing movement of the affected bones. Disruptive Technologies The company has a product portfolio and pipeline of Disruptive Technologies, including MIS, motion preservation, and advanced biomaterials technologies, as well as interventional pain management solutions, including treatments for vertebral compression fractures (VCFs). Its MIS products enable a surgeon to perform a procedure less invasively to minimize tissue disruption and maximize native anatomy, which may lead to patient recovery and fewer approach-related complications. The company’s MARS 3V retractor system facilitates smaller incisions with the use of positionable radiolucent retractor blades to access the surgical site and to allow both direct and radiographic visualization. Its CALIBER, RISE and SIGNATURE interbody spacers are designed for delivery through smaller MIS incisions with streamlined implants and instruments. Its REVOLVE pedicle screw system is designed for MIS screw and rod insertion through small incisions, and utilizes a convenient non-threaded locking cap design. Other Disruptive Technology products, such as TRANSITION, provide for stabilization that is less rigid than traditional pedicle screw systems for natural load distribution to help promote fusion while maintaining stability. Similarly, the company’s motion preservation products, such as SECURE-C and SECURE-CR, are next-generation arthroplasty devices that allow segmental motion, are semi-constrained to enhance stability, and provide alternatives to fusion in the treatment of degenerative conditions. The company’s advanced biomaterials products, including MICROFUSE resorbable bone void filler and CONDUCT ceramic-collagen, are well suited for posterolateral fusion procedures in which its stabilization systems are also used. Its AFFIRM product allows for the treatment of painful VCFs earlier in the continuum of care. Clinical Development Programs In addition to the products the company develops and tests spine products. It received its U.S. Food and Drug Administration (FDA) pre-market approval (PMA) for its

Page 12Next Page
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GM0N:GR €16.60 EUR -0.094

GM0N Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Alphatec Holdings Inc $1.42 USD +0.02
Integra LifeSciences Holdings Corp $45.30 USD -0.22
LDR Holding Corp $25.12 USD +0.61
NuVasive Inc $33.83 USD +0.40
Orthofix International NV $31.51 USD +0.29
View Industry Companies
 

Industry Analysis

GM0N

Industry Average

Valuation GM0N Industry Range
Price/Earnings 31.4x
Price/Sales 4.9x
Price/Book 4.5x
Price/Cash Flow 31.2x
TEV/Sales 4.4x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GLOBUS MEDICAL INC - A, please visit www.globusmedical.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.